Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
01/18/2013 | CA2746717A1 Anti-fungal diaper rash creme |
01/17/2013 | WO2013010136A2 Inhibitors of bruton's tyrosine kinase |
01/17/2013 | WO2013010032A1 Gel compositions of oxymetazoline and methods of use |
01/17/2013 | WO2013009929A2 Lotions derived from renewable resources and absorbent articles comprising same |
01/17/2013 | WO2013009717A1 Virion derived protein nanoparticles for delivering diagnostic or therapeutic agents for the treatment of skin-related diseases |
01/17/2013 | WO2013009543A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
01/17/2013 | WO2013009100A2 Method for manufacturing umbilical cord extract and usage of same |
01/17/2013 | WO2013007961A1 Cosmetic and/or dermatological use of oligosaccharide compounds for preventing and treating stretch marks |
01/17/2013 | WO2013007960A1 Use of oligosaccharide compounds for the prevention and treatment of pathological scars |
01/17/2013 | WO2013007763A1 MODULATORS OF THE NLRP3 INFLAMMASOME IL-1ß PATHWAY FOR THE PREVENTION AND TREATMENT OF ACNE |
01/17/2013 | WO2013007700A1 Pharmaceutical composition comprising oleic acid, palmitic acid, linoleic acid and linolenic acid |
01/17/2013 | WO2013007308A1 Platelet-rich plasma composition for tissue repair and regeneration |
01/17/2013 | WO2012160180A3 Pharmaceutical composition for administration to nails |
01/17/2013 | WO2012160179A3 Topical pharmaceutical composition based on semifluorinated alkanes |
01/17/2013 | WO2012158866A9 Treatment of autoimmune disorders and infections using antagonists of sgk1 activity |
01/17/2013 | WO2012158312A9 Skin and hair regeneration using polysaccharide-based hydrogels |
01/17/2013 | WO2012122451A3 Polymorphs of maxacalcitol and process for the preparation of maxacalcitol |
01/17/2013 | WO2012104025A3 Balneotherapeutic lipid-containing probiotic preparations and their applications |
01/17/2013 | WO2010141694A3 Borinic compositions |
01/17/2013 | US20130018343 Lotions Derived From Renewable Resources and Absorbent Articles Comprising Same |
01/17/2013 | US20130018109 Skin and hair treatments |
01/17/2013 | US20130018084 MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
01/17/2013 | US20130018081 AChE ANTISENSE OLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
01/17/2013 | US20130018067 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
01/17/2013 | US20130018057 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
01/17/2013 | US20130018054 New compounds |
01/17/2013 | US20130018052 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
01/17/2013 | US20130018051 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
01/17/2013 | US20130018042 Toll-Like Receptor Agonist Formulations and Their Use |
01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
01/17/2013 | US20130018036 Substituted indazole derivatives active as kinase inhibitors |
01/17/2013 | US20130018034 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
01/17/2013 | US20130018031 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
01/17/2013 | US20130018028 Bi-(indole-2-aceto)-iron II (Ferrous Indole Acetate) |
01/17/2013 | US20130018023 Compositions for topical administration |
01/17/2013 | US20130018021 2Alpha-Methyl and 2Beta-Methyl Analogs of 19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Their Uses |
01/17/2013 | US20130018020 Inhibitor for melanin, and cosmetic composition containing same |
01/17/2013 | US20130018019 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity |
01/17/2013 | US20130018000 Recombinant filaggrin polypeptides for cell importation |
01/17/2013 | US20130017998 Novel modified galectin 9 proteins and use thereof |
01/17/2013 | US20130017285 Compositions and Methods for Treating Hair Loss |
01/17/2013 | US20130017282 Pain Relieving Composition |
01/17/2013 | US20130017279 Formulations for treatment of skin disorders |
01/17/2013 | US20130017260 Oral pharmaceutical formulations for the treatment of human canities |
01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
01/17/2013 | US20130017227 Wound healing compositions and associated methods |
01/17/2013 | US20130017226 TNF-A and TWEAK Dual Antagonist for the Prophylaxis and Treatment of Autoimmune Diseases |
01/17/2013 | US20130017203 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
01/17/2013 | US20130017197 Stabilized antibody preparations and uses thereof |
01/17/2013 | US20130017193 Antibody formulations |
01/17/2013 | US20130017188 Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
01/17/2013 | US20130017175 Activated mesenchymal stem cells for wound healing and impaired tissue regeneration |
01/17/2013 | US20130017170 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
01/17/2013 | US20130017169 Multimeric forms of therapeutic proteins and uses thereof |
01/17/2013 | US20130017149 Pharmaceutical compounds |
01/17/2013 | CA2841983A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
01/17/2013 | CA2841632A1 Gel compositions of oxymetazoline and methods of use |
01/17/2013 | CA2841080A1 Inhibitors of bruton's tyrosine kinase |
01/17/2013 | CA2839760A1 Use of oligosaccharide compounds for the prevention and treatment of pathological scars |
01/16/2013 | EP2545916A1 Use of coumarin derivatives for the preparation of drugs for treating skin diseases |
01/16/2013 | EP2544698A1 Composition comprising probiotic bacteria for use in the treatment of immune disorders |
01/16/2013 | EP2544691A2 Compound, composition, and method for protecting skin from high energy visible light |
01/16/2013 | EP2544669A1 Adhesive patch for therapeutic agent delivery |
01/16/2013 | EP2544656A2 Probiotic color cosmetic compositions and methods |
01/16/2013 | CN202666021U Microcapsule structure with cordyceps sinensis extract liquor |
01/16/2013 | CN202666019U Microcapsule containing nanometer metal liquid |
01/16/2013 | CN102883736A Peptides for promoting angiogenesis and a use thereof |
01/16/2013 | CN102883732A Compositions comprising extracts of southernwood and an amine compound |
01/16/2013 | CN102882999A Chinese herbal medicine patch film |
01/16/2013 | CN102876666A RNA body and its application |
01/16/2013 | CN102876553A Preparation method of high-quality mung bean liquor |
01/16/2013 | CN102876456A Method for extracting volatile oil and alkaloid from pepper by using subcritical fluid |
01/16/2013 | CN102875681A Anti-alpha v beta 6 antibodies and uses thereof |
01/16/2013 | CN102875645A Thymic humoral factor THF-gamma2, its derivative, their synthetic method, and their application in antitumor drugs |
01/16/2013 | CN102875518A Genipin methyl ether, preparation method and medicine application thereof |
01/16/2013 | CN102875478A Amine salts of a crth2 antagonist |
01/16/2013 | CN102875441A Plexxikon inc |
01/16/2013 | CN102872464A Novel choroidal neovascularization gene therapeutic medicine and use thereof |
01/16/2013 | CN102872395A Medicine for treating pimple and preparation method thereof |
01/16/2013 | CN102872393A Medicine for treating scabies |
01/16/2013 | CN102872390A Traditional Chinese medicinal composition for treating dermatoses |
01/16/2013 | CN102872388A Traditional Chinese medicine composition for treating eczema |
01/16/2013 | CN102872386A Externally applied medicine for treating beriberi |
01/16/2013 | CN102872384A Preparation method of Chinese medicinal wet tissue for treating seborrheic infantile eczema |
01/16/2013 | CN102872375A Traditional Chinese medicine decoction for treating acnes |
01/16/2013 | CN102872372A Traditional Chinese medicine for treating hand verruca plana |
01/16/2013 | CN102872367A Hair loss prevention and hair growing medicament and preparation method thereof |
01/16/2013 | CN102872357A Medicine for oral administration for treating carbuncle, gastritis, gastric ulcer and early gastric cancer and method for preparing medicine for oral administration |
01/16/2013 | CN102872356A Gynecological medicine |
01/16/2013 | CN102872355A Essence-rejuvenating and hair-blacking medicinal liquor |
01/16/2013 | CN102872352A Angelica root and rhizoma arisaematis powder |
01/16/2013 | CN102872341A Traditional Chinese medicine ointment for treating tinea corporis |
01/16/2013 | CN102872337A External liniment for treating scald |
01/16/2013 | CN102872326A Chinese medicinal prescription for whitening and administration method thereof |
01/16/2013 | CN102872317A Chinese medicinal prescription for removing acne and preparation method thereof |
01/16/2013 | CN102872312A Dermatitis treating medicine |
01/16/2013 | CN102872310A Traditional Chinese ointment for treating bedsore |
01/16/2013 | CN102872304A Massage oil for preventing and treating bedsore |
01/16/2013 | CN102872302A Acne removal stock liquid |
01/16/2013 | CN102872279A Tablets for clearing away lower energizer and dampness-heat |